scholarly article | Q13442814 |
P2093 | author name string | Kun Yao | |
Qiang Ding | |||
Li-Zong Shen | |||
Wen-Xi Wu | |||
Yi-Bing Hua | |||
Xin-Yuan Liu | |||
De-Hua Xu | |||
Zhong-Cheng Zheng | |||
P2860 | cites work | An integrin-targeted non-viral vector for pulmonary gene therapy | Q45865697 |
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system | Q45867740 | ||
Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration | Q45868332 | ||
The Construction of an Adenovirus Vector Containing Cytosine Deaminase Gene and Its Application. | Q54540137 | ||
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer | Q73814757 | ||
[Tumor markers for colorectal cancer] | Q74576753 | ||
Targeting adenovirus | Q33837127 | ||
Modifying the host range properties of retroviral vectors | Q33876131 | ||
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. | Q34005910 | ||
Gene therapy for colorectal cancer: therapeutic potential | Q34344921 | ||
Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy. | Q36397313 | ||
The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer | Q36397443 | ||
Inhibitory effect of IGF- II antisense RNA on malignant phenotype of hepatocellular carcinoma | Q36491922 | ||
The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo | Q36506433 | ||
Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA & DTA gene transfer | Q36620118 | ||
Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line. | Q40753765 | ||
Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase | Q40769500 | ||
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis | Q40897254 | ||
Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system. | Q40943665 | ||
Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter. | Q43573063 | ||
Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir | Q43687893 | ||
In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy | Q43705366 | ||
Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model. | Q43708562 | ||
Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases. | Q43710414 | ||
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase | Q43796867 | ||
Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene | Q43809709 | ||
Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. | Q44107370 | ||
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. | Q45861917 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Adenoviridae | Q193447 |
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 270-275 | |
P577 | publication date | 2002-04-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene | |
P478 | volume | 8 |
Q35085995 | Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer |
Q40541147 | Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901. |
Q40115005 | Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells |
Q40061667 | Construction of humanized carcinoembryonic antigen specific single chain variable fragment and mitomycin conjugate |
Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
Q36178667 | Pre-operative radiochemotherapy of locally advanced rectal cancer |
Q40498934 | Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer |
Q39688817 | Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell |
Q39476525 | The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro |
Q40651834 | Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29 |
Search more.